Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma

pharmaceutical-technologyMay 11, 2017

Tag: neuroblastoma , EC , antibody

PharmaSources Customer Service